Home › Funds › C WorldWide Group Holding A/S › NBIX

C WorldWide Group Holding A/S position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

C WorldWide Group Holding A/S reported holding 125,000 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$17.7M, representing 0.45% of its reported portfolio and ranking #36 among its reported holdings. C WorldWide Group Holding A/S has disclosed NBIX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)125.00K sh
Reported value held$17.73M
Portfolio Weight0.45%
First reportedQ2 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How C WorldWide Group Holding A/S's NBIX position evolved

C WorldWide Group Holding A/S first disclosed a stake in NBIX in Q2 2024 at 75,000 shares (US$10.3M). The position peaked in Q2 2026 at 125,000 shares, worth US$21.1M. Across 10 filings, C WorldWide Group Holding A/S increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 125,000 shares valued at US$17.7M. Notable position changes include a 27% increase in Q3 2024 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 75.00K $10.32M New
Q3 2024 95.00K $10.95M Add
Q4 2024 115.00K $15.70M Add
Q1 2025 115.00K $12.72M Hold
Q2 2025 135.00K $16.97M Add
Q3 2025 125.00K $17.55M Reduce
Q4 2025 125.00K $17.73M Hold
Q1 2026 125.00K $16.47M Hold
Q2 2026 125.00K $21.07M Hold
Q3 2026 125.00K $17.73M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 30 other funds we track also report a position in NBIX — the largest reported positions include Two Sigma Investments (US$349.9M), Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has C WorldWide Group Holding A/S held NBIX?

C WorldWide Group Holding A/S has disclosed NBIX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is C WorldWide Group Holding A/S's current position in NBIX?

As of Q3 2026, C WorldWide Group Holding A/S holds 125.00K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $17.73M, representing 0.45% of its reported portfolio and ranking #36.

Has C WorldWide Group Holding A/S been buying or selling NBIX?

In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in NBIX. The position peaked in Q2 2026 at 125.00K shares.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Two Sigma Investments, Renaissance Technologies, Vestal Point Capital, LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.